Despite beneficial metabolic effects of TGR5 agonists in mice, including lower glucose levels and improved lipid profiles, the TGR5 agonist SB-756050 increased fasting glucose levels compared to placebo in human subjects with type 2 diabetes [144]. The gene discussed is GPBAR1; the disease is type 2 diabetes mellitus.